As the importance of validation and qualification is continuously required and the high-quality final products (medicine, etc.) is demanded in the bio and pharmaceutical industry, the demand for RM (Risk Management) and DR (Design Review) is rapidly increased beyond the past simple IQ (Installation Qualification) and OQ (Operational Qualification).
Therefore, GCEM executes DQ (Design Qualification), IQ (Installation Qualification) and OQ (Operational Qualification) and provides risk management service based on risk analysis.